PetMed Express, Inc.

PetMed Express, Inc.

PETS · Nasdaq

PetMed Express, Inc. (PETS) is a Medical pharmaceuticals company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for PetMed Express, Inc. in 2026. The next earnings report is expected on November 10, 2026.

Earnings calendar

Next earnings date

10 Nov 2026

In 83 days

EPS estimate

-0.06

Revenue estimate

62.0M

Past earnings

13 Aug 2026
EPS actual
-0.28 (-333.3%)
estimate 0.12
Revenue actual
41.0M (-42.2%)
estimate 71.0M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
02 Jun 2026
EPS actual
-0.19 (-5.6%)
estimate -0.18
Revenue actual
42.8M (-17.7%)
estimate 52.0M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
05 Feb 2026
EPS actual
-0.50 (-733.3%)
estimate -0.06
Revenue actual
—
estimate 54.0M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
19 Dec 2025
EPS actual
—
estimate 0.04
Revenue actual
—
estimate 60.8M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
Beat Miss usd

Latest earnings analysis

PetMed Express, Inc. missed consensus estimates in its latest earnings, with EPS of $-0.28 falling 333.3% short of expectations and revenue of $41.02 million missing estimates by 42.2%. In the prior report both EPS and revenue also missed expectations.

Dividend calendar

No dividend history available.

EPS (Earnings Per Share)

Revenue

Company profile

PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; telephone contact center; and direct mail/print, which includes brochures and postcards, as well as television advertising under the 1-800-PetMeds and PetMeds brands. PetMed Express, Inc. was incorporated in 1996 and is headquartered in Delray Beach, Florida.

Sector
Healthcare
Industry
Medical pharmaceuticals
Country
United States
Exchange
Nasdaq
CEO
Leslie C. G. Campbell
Employees
287
IPO date
26 Apr 1999
ISIN
US7163821066
Website
1800petmeds.com

Frequently asked questions

When does PetMed Express, Inc. (PETS) next report earnings?

PetMed Express, Inc. (PETS) is scheduled to report earnings on November 10, 2026.

What was PetMed Express, Inc.'s most recent earnings date?

PetMed Express, Inc. (PETS) last reported earnings on August 13, 2026.

Where is PetMed Express, Inc. stock listed?

PetMed Express, Inc. (PETS) is listed on Nasdaq.